Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A role for IL-4 in immunologically mediated enteropathy

A M Mowat¹, M B Widmer

¹Department of Immunology, University of Glasgow, Western Infirmary, UK.

Clinical and Experimental Immunology

|January 1, 1995

Summary

Interleukin-4 (IL-4) plays a key role in the proliferative aspects of intestinal immunopathology during graft-versus-host reactions. Targeting IL-4 may offer a novel therapeutic strategy for enteropathies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Colonic tolerance develops in the iliac lymph nodes and can be established independent of CD103(+) dendritic cells.

Mucosal immunology·2015

Same author

The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct.

Mucosal immunology·2015

Same author

The regulation of immune responses to dietary protein antigens.

Immunology today·2014

Same author

Contrasuppressor cells in mucosal immunity.

Immunology today·2014

Same author

CCR2(+)CD103(-) intestinal dendritic cells develop from DC-committed precursors and induce interleukin-17 production by T cells.

Mucosal immunology·2014

Same author

Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.

Mucosal immunology·2014

Area of Science:

Immunology
Gastroenterology
Cytokine Biology

Background:

Clinical enteropathies are linked to local cell-mediated immune responses.
Cytokines are implicated as mediators of intestinal pathology in these conditions.

Purpose of the Study:

To investigate the specific role of Interleukin-4 (IL-4) in the intestinal manifestations of graft-versus-host reactions (GVHR).
To determine if targeting IL-4 could prevent or mitigate intestinal immunopathology.

Main Methods:

Depletion of IL-4 using monoclonal antibodies (MoAb) or a soluble IL-4 receptor (IL-4R).
Assessment of jejunal pathology, including crypt hyperplasia and intraepithelial lymphocyte (IEL) recruitment, in a proliferative GVHR model.
Evaluation of villus atrophy in a destructive GVHR model and systemic immunity indices.

Main Results:

IL-4 depletion prevented jejunal manifestations (crypt hyperplasia, IEL recruitment) in a proliferative GVHR model.
IL-4 depletion did not affect villus atrophy in a destructive GVHR model.
Systemic immunity indices remained unaffected by IL-4 depletion.

Conclusions:

IL-4 selectively mediates proliferative aspects of intestinal immunopathology in GVHR.
IL-4 represents a potential therapeutic target for specific enteropathies characterized by proliferative changes.

Related Experiment Videos